Cincinnati Clinical Research Site (Site 2401)

Cincinnati, Ohio 45267-0405

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections, Hepatitis B

Studies at this site

• Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV — Completed